Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

A new mutation in the ST14 gene causes a rare skin and hair disorder in a specific family.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Found 32 genes linked to male baldness, affecting hair growth and stress-related pathways.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

HSL treatment speeds up hair growth and reduces oxidative stress in hair follicles of ob/ob mice.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Hair loss doesn't affect COVID-19 severity.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Scientists successfully purified a protein called Wnt3a, which is involved in processes like hair growth, but the overall yield was low, suggesting more work is needed to improve this.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Docosahexaenoic acid (DHA) may help hair growth by promoting dermal papilla cell proliferation.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Touching cats can increase the risk of getting a fungal scalp infection, especially in boys and kids over 5.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.